182 related articles for article (PubMed ID: 31221253)
1. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
Arundel C; Lam PH; Gill GS; Patel S; Panjrath G; Faselis C; White M; Morgan CJ; Allman RM; Aronow WS; Singh SN; Fonarow GC; Ahmed A
J Am Coll Cardiol; 2019 Jun; 73(24):3054-3063. PubMed ID: 31221253
[TBL] [Abstract][Full Text] [Related]
2. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
Tsimploulis A; Lam PH; Arundel C; Singh SN; Morgan CJ; Faselis C; Deedwania P; Butler J; Aronow WS; Yancy CW; Fonarow GC; Ahmed A
JAMA Cardiol; 2018 Apr; 3(4):288-297. PubMed ID: 29450487
[TBL] [Abstract][Full Text] [Related]
3. Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension.
Faselis C; Lam PH; Zile MR; Bhyan P; Tsimploulis A; Arundel C; Patel S; Kokkinos P; Deedwania P; Bhatt DL; Zeng-Trietler Q; Morgan CJ; Aronow WS; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2021 Apr; 134(4):e252-e263. PubMed ID: 33010225
[TBL] [Abstract][Full Text] [Related]
4. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
Lam PH; Dooley DJ; Deedwania P; Singh SN; Bhatt DL; Morgan CJ; Butler J; Mohammed SF; Wu WC; Panjrath G; Zile MR; White M; Arundel C; Love TE; Blackman MR; Allman RM; Aronow WS; Anker SD; Fonarow GC; Ahmed A
J Am Coll Cardiol; 2017 Oct; 70(15):1861-1871. PubMed ID: 28982499
[TBL] [Abstract][Full Text] [Related]
5. Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
Malik A; Masson R; Singh S; Wu WC; Packer M; Pitt B; Waagstein F; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
J Am Coll Cardiol; 2019 Aug; 74(5):617-627. PubMed ID: 31370952
[TBL] [Abstract][Full Text] [Related]
6. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.
Ambrosy AP; Vaduganathan M; Mentz RJ; Greene SJ; Subačius H; Konstam MA; Maggioni AP; Swedberg K; Gheorghiade M
Am Heart J; 2013 Feb; 165(2):216-25. PubMed ID: 23351825
[TBL] [Abstract][Full Text] [Related]
7. Initiation of anti-hypertensive drugs and outcomes in patients with heart failure with preserved ejection fraction and persistent hypertension.
Lam PH; Tsimploulis A; Patel S; Raman VK; Arundel C; Faselis C; Deedwania P; Sheikh FH; Banerjee SK; Allman RM; Fonarow GC; Aronow WS; Ahmed A
Prog Cardiovasc Dis; 2022; 73():17-23. PubMed ID: 35777433
[TBL] [Abstract][Full Text] [Related]
8. Initiation of Anti-Hypertensive Drugs and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction.
Lam PH; Aronow WS; Tsimploulis A; Bhyan P; Allam SD; Patel S; Raman VK; Arundel C; Sheikh FH; Kanonidis IE; Deedwania P; Allman RM; Fonarow GC; Faselis C; Ahmed A
Am J Med; 2022 Jun; 135(6):737-744. PubMed ID: 34861194
[TBL] [Abstract][Full Text] [Related]
9. Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF.
Verma AK; Sun JL; Hernandez A; Teerlink JR; Schulte PJ; Ezekowitz J; Voors A; Starling R; Armstrong P; O'Conner CM; Mentz RJ
Clin Cardiol; 2018 Jul; 41(7):945-952. PubMed ID: 29781109
[TBL] [Abstract][Full Text] [Related]
10. Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction.
Malik A; Gill GS; Lodhi FK; Tummala LS; Singh SN; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Jan; 133(1):84-94. PubMed ID: 31336093
[TBL] [Abstract][Full Text] [Related]
11. Relation of baseline systolic blood pressure and long-term outcomes in ambulatory patients with chronic mild to moderate heart failure.
Banach M; Bhatia V; Feller MA; Mujib M; Desai RV; Ahmed MI; Guichard JL; Aban I; Love TE; Aronow WS; White M; Deedwania P; Fonarow G; Ahmed A
Am J Cardiol; 2011 Apr; 107(8):1208-14. PubMed ID: 21296319
[TBL] [Abstract][Full Text] [Related]
12. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction.
Serenelli M; Jackson A; Dewan P; Jhund PS; Petrie MC; Rossignol P; Campo G; Pitt B; Zannad F; Ferreira JP; McMurray JJV
JACC Heart Fail; 2020 Mar; 8(3):188-198. PubMed ID: 31926854
[TBL] [Abstract][Full Text] [Related]
14. Lack of evidence of lower 30-day all-cause readmission in Medicare beneficiaries with heart failure and reduced ejection fraction discharged on spironolactone.
Lam PH; Dooley DJ; Inampudi C; Arundel C; Fonarow GC; Butler J; Wu WC; Blackman MR; Anker MS; Deedwania P; White M; Prabhu SD; Morgan CJ; Love TE; Aronow WS; Allman RM; Ahmed A
Int J Cardiol; 2017 Jan; 227():462-466. PubMed ID: 27866868
[TBL] [Abstract][Full Text] [Related]
15. Digoxin Use and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
Qamer SZ; Malik A; Bayoumi E; Lam PH; Singh S; Packer M; Kanonidis IE; Morgan CJ; Abdelmawgoud A; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2019 Nov; 132(11):1311-1319. PubMed ID: 31150644
[TBL] [Abstract][Full Text] [Related]
16. The association between admission systolic blood pressure of heart failure patients with preserved systolic function and mortality outcomes.
Rosman Y; Kopel E; Shlomai G; Goldenberg I; Grossman E
Eur J Intern Med; 2015 Dec; 26(10):807-12. PubMed ID: 26525208
[TBL] [Abstract][Full Text] [Related]
17. Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction.
Ueda T; Kawakami R; Nakada Y; Nakano T; Nakagawa H; Matsui M; Nishida T; Onoue K; Soeda T; Okayama S; Watanabe M; Okura H; Saito Y
ESC Heart Fail; 2019 Oct; 6(5):1057-1067. PubMed ID: 31325235
[TBL] [Abstract][Full Text] [Related]
18. Impact of baseline systolic blood pressure on long-term outcomes in patients with advanced chronic systolic heart failure (insights from the BEST trial).
Desai RV; Banach M; Ahmed MI; Mujib M; Aban I; Love TE; White M; Fonarow G; Deedwania P; Aronow WS; Ahmed A
Am J Cardiol; 2010 Jul; 106(2):221-7. PubMed ID: 20599007
[TBL] [Abstract][Full Text] [Related]
19. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
[TBL] [Abstract][Full Text] [Related]
20. Association of Arterial Pulse Pressure With Long-Term Clinical Outcomes in Patients With Heart Failure.
Laskey WK; Wu J; Schulte PJ; Hernandez AF; Yancy CW; Heidenreich PA; Bhatt DL; Fonarow GC
JACC Heart Fail; 2016 Jan; 4(1):42-9. PubMed ID: 26656142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
